Finance

Beta
Lists
300636:SHE
Jiangxi Synergy Pharmaceutical Co Ltd
CN¥6.61
-0.90%
(-0.060) 1D
Jun 16, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300636...
Open
CN¥6.67
High
CN¥6.69
Low
CN¥6.49
Mkt. cap
2.80B
Avg. vol.
5.73M
Volume
4.80M
Dividend
0.61%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
39.05
52-wk high
CN¥9.48
52-wk low
CN¥6.49
EPS
CN¥0.17
Shares outstanding
419.95M
No. of employees
2K
Open
CN¥6.67
High
CN¥6.69
Low
CN¥6.49
Mkt. cap
2.80B
Avg. vol.
5.73M
Volume
4.80M
Dividend
0.61%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
39.05
52-wk high
CN¥9.48
52-wk low
CN¥6.49
EPS
CN¥0.17
Shares outstanding
419.95M
No. of employees
2K
News stories
From sources across the web
About Jiangxi Synergy Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedApr 20, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
240.52M
208.82M
192.42M
184.39M
Cost of goods sold
184.88M
120.66M
199.99M
131.75M
Cost of revenue
184.88M
120.66M
199.99M
131.75M
Research and development expenses
12.51M
14.39M
23.96M
15.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.00M
18.28M
19.11M
16.05M
Operating expense
31.67M
33.51M
44.05M
29.36M
Total operating expenses
216.55M
154.17M
244.04M
161.11M
Operating income
23.98M
54.65M
-51.62M
23.29M
Other non operating income
-1.06M
3.20M
-3.77M
-863.12K
EBT including unusual items
42.54M
27.84M
-16.84M
19.62M
EBT excluding unusual items
30.28M
56.95M
-51.51M
20.10M
Income tax expense
4.83M
2.66M
-6.27M
836.49K
Effective tax rate
11.36%
9.55%
37.22%
4.26%
Other operating expenses
4.63M
301.57K
1.24M
-2.65M
Net income
37.71M
25.18M
-10.57M
18.78M
Net profit margin
15.68%
12.06%
-5.49%
10.18%
Earnings per share
-
-
-
-
Interest and investment income
6.87M
6.16M
5.57M
-
Interest expense
-3.57M
-2.98M
-2.95M
-2.33M
Net interest expenses
3.30M
3.17M
2.61M
-2.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
57.64M
83.08M
-19.08M
55.82M
Gain or loss from assets sale
194.30K
-194.30K
767.63K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more